NorrChemica™
PyOxim
PyOxim | CAS 153433-21-7 | ≥95%
Couldn't load pickup availability
Technical Specifications
| CAS Number | 153433-21-7 |
| EC / EINECS Number | 663-448-1 |
| MDL Number | MFCD18643381 |
| SMILES | CCOC(=O)/C(=N/O[P+](N1CCCC1)(N2CCCC2)N3CCCC3)/C#N.F[P-](F)(F)(F)(F)F |
| InChI | InChI=1S/C17H29N5O3P.F6P/c1-2-24-17(23)16(15-18)19-25-26(20-9-3-4-10-20,21-11-5-6-12-21)22-13-7-8-14-22;1-7(2,3,4,5)6/h2-14H2,1H3;/q+1;-1/b19-16+; |
| InChIKey | RDWDVLFMPFUBDV-PXMDEAMVSA-N |
| PubChem CID | 46910530 |
| Molecular Formula | C₁₇H₂₉F₆N₅O₃P₂ |
| Molecular Weight | 527.38 g/mol |
| Melting Point | 172 °C |
| Solubility | Soluble in DMF, DCM, NMP; insoluble in water, diethyl ether |
| Purity | ≥95% |
| Physical Form | White powder |
| HS Code | 2926.90 |
| Shelf Life | Retest period: 36 months from date of manufacture |
| Storage Conditions | Store refrigerated (2–8 °C) in a tightly sealed container under inert atmosphere, protected from moisture |
Product Description & Scientific Applications
PyOxim ([ethyl cyano(hydroxyimino)acetato-O²]tri-1-pyrrolidinylphosphonium hexafluorophosphate) is a phosphonium-type peptide coupling reagent that pairs the Oxyma leaving group (ethyl 2-cyano-2-(hydroxyimino)acetate) with a tripyrrolidinophosphonium cation and a hexafluorophosphate counterion. It belongs to the non-benzotriazole, Oxyma-based family of coupling reagents. In the presence of a tertiary-amine base such as DIPEA it activates a carboxylic acid as the corresponding Oxyma-based active ester, which then acylates the amine to form the amide bond. Its coupling efficiency is comparable to COMU; in demanding model couplings it outperformed the benzotriazole-based phosphonium reagents PyBOP, PyAOP and PyClock, with low racemisation. Because it carries a phosphonium rather than an aminium centre, PyOxim cannot guanidinylate the free amine of the growing chain — a chain-terminating side reaction associated with aminium reagents such as HATU and HBTU. It dissolves readily in DMF and is used in solid- and solution-phase peptide synthesis.
Common Scientific Applications
Solid- and solution-phase peptide synthesis: PyOxim is a phosphonium coupling reagent for solid- and solution-phase peptide-bond formation, activating protected amino acids with high coupling efficiency and low racemisation across short to demanding sequences.
Cyclic peptide synthesis and fragment condensation: Because it forms no guanidinated by-products, PyOxim preserves the free N-terminus during convergent fragment (segment) condensation and peptide cyclisation. In cyclisation models it delivered a higher proportion of cyclic product than other established phosphonium salts, supporting its use in cyclic-peptide work.
Sterically hindered and configurationally labile couplings: The Oxyma-based activation couples demanding residues — including consecutive α-aminoisobutyric acid (Aib) and other hindered amino acids — with low epimerisation, in model couplings where benzotriazole-based phosphonium reagents give lower conversion.
Stable reagent solutions: PyOxim combines high solubility in DMF with good stability in solution, so activator solutions prepared in advance remain usable longer than those of less stable reagents — useful wherever reagent solutions stand before use, including automated multi-cycle synthesis.
Further Reading
For guidance on selecting between carbodiimides, aminium/uronium salts, phosphonium salts, and other reagent classes for amide and peptide bond formation, see NorrChemica's Lab Journal guide: Choosing a Coupling Reagent for Amide and Peptide Bond Formation.
Shipping Destinations
- EU & UK: Priority delivery, 2–5 business days.
- United States (DDP): 3–7 business days, duties and taxes prepaid.
- EFTA Countries (DDP): 3–7 business days, duties and taxes prepaid.
- Worldwide: 7–14 business days, selected locations.
Safety Information
| Hazard Class | None — not subject to transport regulations |
| Transport Category | Not classified as dangerous goods for transport (ADR/IATA/IMDG) |
Documentation
| Safety Data Sheet | Download PDF |
Share
